關於這個 Podcast 🔗

主持人:
更新頻率:
every 9 days
平均音訊長度:
24 minutes
嘉賓訪談
有贊助商
影片 Podcast
英語
美國
416 集
自從 2016年9月14日
episodic

最新一集 🔗

Eileen M. O'Reilly, MD, FASCO - Hope Is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer

搜尋以前的節目

搜尋PeerVoice Oncology & Haematology Video以前的節目。

以前的節目

Eric Van Cutsem, MD, PhD - Biology that Transcends Tumour Type: Integrating Tumour-Agnostic With Tumour-Specific Treatments for HER2-Positive Gastrointestinal Cancers
Jeffrey Weitz, MD, OC, FRCP(C) - Assessing the Potential of Factor XIa Inhibition for Secondary Stroke Prevention: Supporting Our Cross-Specialty Colleagues in Improving Patient Outcomes
Giannis Mountzios, MD, PhD - Preparing to Turn Potential Into Progress in ES-SCLC: The Practicalities of DLL3-Targeted T-Cell Engagers
Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient Outcomes
Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment Outcomes
One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings
Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge
免責聲明: 本頁面嵌入的 Podcast 和封面圖片來自 PeerVoice,歸其所有者所有,與 Listen Notes, Inc. 無關聯,也未獲得 Listen Notes, Inc. 背書。